To systematically detail the biological properties of tertiary lymphoid structures (TLS) in head and neck cancer (HNC), emphasizing their clinical significance as biomarkers and potential therapeutic targets.
Key Findings:
Mature intra-tumoral TLS are significantly associated with enhanced patient prognosis, as evidenced by clinical studies.
TLS are linked to increased efficacy of immunotherapy in HNC, suggesting a role in treatment response.
TLS serve as a central core of tumor immunity, initiating and maintaining adaptive anti-tumor immune responses.
Interpretation:
TLS play a crucial role in the tumor microenvironment of HNC, acting as potential biomarkers for prognosis and immunotherapy response, highlighting the need for improved detection methods.
Limitations:
Lack of standardized evaluation frameworks for TLS, which complicates comparative studies.
Need for non-invasive detection methods to facilitate clinical application.
Functional diversity of TLS across various HNC subtypes is not fully understood, limiting generalizability.
Conclusion:
Despite the promising role of TLS in HNC management, further research is needed to address existing challenges and enhance their clinical application, which could significantly improve patient outcomes.
